These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28435691)

  • 1. Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations.
    Garner SA; Rennie S; Ananworanich J; Dube K; Margolis DM; Sugarman J; Tressler R; Gilbertson A; Dawson L
    J Virus Erad; 2017 Apr; 3(2):82-84. PubMed ID: 28435691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption.
    Peluso MJ; Dee L; Campbell D; Taylor J; Hoh R; Rutishauser RL; Sauceda J; Deeks SG; Dubé K
    J Virus Erad; 2020 Feb; 6(1):34-37. PubMed ID: 32175090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.
    Dubé K; Evans D; Dee L; Sylla L; Taylor J; Skinner A; Weiner BJ; Greene SB; Rennie S; Tucker JD
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):67-79. PubMed ID: 28562069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom.
    Lee MJ; Godakandaarachchi P; Collins S; Racz M; Sharp A; Fidler S; Fox J
    J Virus Erad; 2023 Dec; 9(4):100360. PubMed ID: 38188642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A partner protection package for HIV cure-related trials involving analytical treatment interruptions.
    Dubé K; Morton T; Fox L; Dee L; Palm D; Villa TJ; Freshwater W; Taylor J; Graham G; Carter WB; Sauceda JA; Peluso MJ; Rid A
    Lancet Infect Dis; 2023 Oct; 23(10):e418-e430. PubMed ID: 37295453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions.
    Polizzotto MN; Chen G; Tressler RL; Godfrey C
    Drugs; 2015 Sep; 75(13):1447-59. PubMed ID: 26224205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards an HIV cure.
    Deeks S
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19479. PubMed ID: 25393988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
    Pai NP; Lawrence J; Reingold AL; Tulsky JP
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006148. PubMed ID: 16856117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing Combined HIV Vaccine Strategies for a Functional Cure.
    Noto A; Trautmann L
    Vaccines (Basel); 2013 Oct; 1(4):481-96. PubMed ID: 26344343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV cure research: a formidable challenge.
    Ananworanich J; Fauci AS
    J Virus Erad; 2015 Jan; 1(1):1-3. PubMed ID: 27482389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV cure : a realistic perspective ?].
    Darcis G; Moutschen M
    Rev Med Liege; 2017 Sep; 72(9):388-392. PubMed ID: 28892313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.
    Wang Z; Simonetti FR; Siliciano RF; Laird GM
    Retrovirology; 2018 Feb; 15(1):21. PubMed ID: 29433524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.
    Delannoy A; Poirier M; Bell B
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alphabet Soup of HIV Reservoir Markers.
    Sharaf RR; Li JZ
    Curr HIV/AIDS Rep; 2017 Apr; 14(2):72-81. PubMed ID: 28401492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.
    Rainwater-Lovett K; Ziemniak C; Watson D; Luzuriaga K; Siberry G; Petru A; Chen Y; Uprety P; McManus M; Ho YC; Lamers SL; Persaud D
    PLoS One; 2017; 12(2):e0170548. PubMed ID: 28178277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring HIV Persistence on Antiretroviral Therapy.
    Horsburgh BA; Palmer S
    Adv Exp Med Biol; 2018; 1075():265-284. PubMed ID: 30030797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV cure research: advances and prospects.
    Passaes CP; Sáez-Cirión A
    Virology; 2014 Apr; 454-455():340-52. PubMed ID: 24636252
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.